Which stocks are moving on Monday? Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Keep an eye on the top gainers and losers in Monday's session. Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
These stocks are moving in today's after hours session Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Dyne Therapeutics Stock Drops After ‘Surprise’ Pivot In Primary Endpoint For Muscle Drug Trial The updated study will enroll 60 participants and track additional measures like muscle strength, mobility, and patient-reported outcomes.
Which stocks are moving on Tuesday? Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Why Is Dyne Therapeutics Stock Trading Lower On Tuesday? Dyne updates DYNE-101 trial timeline, reports strong 12-month data, and receives FDA Breakthrough Therapy status for treating DM1.
Get insights into the top gainers and losers of Tuesday's pre-market session. Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Curious about the stocks that are showing activity after the closing bell on Monday? Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly.
JPMorgan Seeks Clarity On Dyne Therapeutics' DYNE-101 Expansion, Regulatory Path JP Morgan analysts question Dyne Therapeutics' strategy for DYNE-101 in DM1, highlighting regulatory uncertainty and investor concerns over data updates.
